All articles by Preeti Behuria
Preeti Behuria
LucidHealth partners with Aidoc for radiology AI
Radiology management firm LucidHealth has entered into a partnership with Aidoc to bring advanced radiology artificial intelligence (AI) to healthcare sites in the Midwest region of the US.
Janssen and Apple launch Heartline study
Janssen Pharmaceutical Companies of Johnson & Johnson (J&J) has entered into a partnership with Apple to open enrollment for a Heartline study intended to obtain information on heart health among individuals aged 65 and older.
7D Surgical receives approvals for Cranial Biopsy Kit
Canada-based 7D Surgical has secured 510(k) clearance from the US Food and Drug Administration (FDA), as well as the Health Canada medical device license (MDL) for its Cranial Biopsy Kit.
Abbott’s CATALYST trial secures FDA approval for stroke patients
Abbott has received approval from the US Food and Drug Administration (FDA) to commence a new trial for the evaluation of its Amplatzer Amulet left atrial appendage (LAA) occluder to treat people with atrial fibrillation (AF).
FDA approves BioElectronics’ ActiPatch for musculoskeletal pain
Non-invasive electroceutical devices manufacturer BioElectronics has received 510(k) approval from the US Food and Drug Administration (FDA) for its drug-free ActiPatch medical device.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Coronavirus: Australian researchers grow the virus in lab
Scientists in Australia have developed the deadly coronavirus, becoming the first to recreate the virus outside China.
IDbyDNA’s Explify Respiratory Test can detect coronavirus
US-based metagenomics technology firm IDbyDNA has announced the company’s Explify Respiratory test can detect new coronavirus (2019-nCoV).
BioIntelliSense secures FDA approval for BioSticker on-body sensor
BioIntelliSense has received 510(k) approval from the US Food and Drug Administration (FDA) for its BioSticker on-body sensor for scalable remote care.
Mauna Kea gets FDA approval for Cellvizio with fluorescein dye
Mauna Kea Technologies, France has secured the US Food and Drug Administration (FDA) 510(k) approval for Cellvizio 100 series and all associated Confocal Miniprobes for visualisation of blood flow when used with drug combination fluorescein.
Imricor receives CE Mark approval for Vision-MR Ablation Catheter
Imricor Medical Systems has secured CE mark approval for its Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode for carrying out cardiac catheter ablations directed by real-time MRI.